Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

clinical trialsClinicalTrials.govT1Dtrial matching

What this is and is not

This is a discovery layer for official trial records. It is not an eligibility decision, treatment recommendation, or invitation to share private health information.

A useful trial watch should help a family ask better questions: Who is eligible? What is the intervention? Where is the site? What is the burden? What endpoints are being measured?

Recruiting records to inspect

Denosumab for Type 1 Diabetes — RECRUITING, PHASE1, PHASE2. Interventions: Denosumab, Placebo. Locations: Birmingham, Alabama, United States | Duarte, California, United States | Indianapolis, Indiana, United States. Type 1 diabetes (T1D) arises from...Source
Open-Label Study of Dimethyl Fumarate in Adults With Type 1 Diabetes — RECRUITING, PHASE2, PHASE3. Interventions: Dimethyl Fumarate Enteric-coated Capsules, Insulin. Locations: Nanjing, Jiangsu, China. This is a non-randomized, parallel-controlled, single-center, open-label clinical trial...Source
Impact of MEnstruation on Glycemic Response and Exercise In Females With Type 1 Diabetes — RECRUITING, NA. Interventions: Personalized modifications to treatment to address menstrual cycle effects on glycemia. Locations: Aurora, Colorado, United States. The objectives of this study are to examine how sex horm...Source
A Randomized Parallel Clinical Trial of AIDANET, an Automated Insulin Delivery Algorithm, in Fully Closed-Loop Vs Hybrid Closed-Loop Mode In Adults With Type 1 Diabetes (AIDANET At Home) — RECRUITING, NA. Interventions: AIDANET + FCL, AIDANET + HCL, AIDANET in FCL-HCL-mixed mode. Locations: Charlottesville, Virginia, United States. A randomized cross-over trial assessing glycemic control on Automated insu...Source
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss — RECRUITING, NA. Interventions: Myfortic. Locations: Miami, Florida, United States. This is a single-center, prospective, open label study in islet transplant recipients after complete islet graft rejection/loss, defined...Source
Clamp Study to Estimate the Relative Potency of GZR33 Versus Insulin Degludec at Steady State — RECRUITING, PHASE1. Interventions: GZR-33. Locations: Neuss, Germany | Neuss, Germany. This trial intends to investigate the pharmacodynamics, pharmacokinetics, safety, and tolerability of insulin GZR33 (hereafter refer...Source
Characterization of Autoreactive Regulatory and Conventional CD4 T Cells in Recent Onset Type 1 Diabetes and Control Individuals — RECRUITING, NA. Interventions: Frequency of Treg and Teffs, Phenotype of Treg and Teffs, RNA seq analysis. Locations: Paris, France. Type 1 diabetes (T1D) is caused by an autoimmune response leading to the destruction o...Source
UK Islet Autoantibody Registry — RECRUITING. Locations: Oxford, Oxfordshire, United Kingdom. Type 1 diabetes (T1D) is a life-long condition where the immune system destroys part of the body (the pancreas) which makes the chemical, insulin. Insulin is n...Source

Questions before contacting a study

Is the study specifically for Type 1 diabetes, and does it match the participant age, disease stage, and treatment context?
What travel, visit frequency, labs, devices, medication changes, and hypoglycemia risk are involved?
Can the family discuss the official record with their endocrinology team before sharing additional personal health details?

This article is an evidence-labeled information brief, not medical advice. Use the linked source records and your care team before making treatment decisions.